Introduction
Malignant fibrous histiocytoma (MFH), currently classified as undifferentiated pleomorphic sarcoma, is the most frequent soft tissue sarcoma in adulthood, but it is not as common as a primary skin tumor [1] . The age of presentation ranges between 50 and 70 years, two-thirds occur among men, and the Caucasian population is more commonly affected. MFH affects mostly the thighs and trunk. Infrequently, it presents in the head and neck in adults [2, 3] . The lesions are usually diagnosed in advanced stages, and despite currently proposed therapies such as radiotherapy or chemotherapy, the patient's prognosis is usually poor with a tendency to local recurrence and systemic metastasis [1] . Early recognition is crucial to improve clinical outcome. Dermoscopy has shown to be useful in the assessment of both melanoma and non-melanoma skin tumors [4] .
Case Report
A 75-year-old male with history of multiple basal cell carcinomas and actinic keratosis presented for a biannual routine skin examination. In the left cheek a hypopigmented lesion was detected. It was discretely erythematous, with poorly defined limit, and increased consistency on palpation ( Figure   1 , German Sanchez-Granel 2 , Mario Gorosito
Malignant fibrous histiocytoma (MFH), currently classified as undifferentiated pleomorphic sarcoma, is the most frequent soft tissue sarcoma in adulthood, but it is not as common as a primary skin tumor. MFH affects mostly the thighs and trunk, head and neck is an infrequent presentation in adults. MFH is often diagnosed in advanced stages, with a tendency to local recurrence and systemic metastasis.
Since tumor thickness and size are identified as major prognostic factors, early recognition becomes crucial to improve prognosis. We present a case of a cutaneous malignant fibrous histiocytoma located on the face in which dermoscopy was useful in clinical management and definition.
ABSTRACT
Observation | Dermatol Pract Concept 2017;7(3):9 45 irregular cells, some giant, with large and hyperchromatic nuclei and high mitotic index, which adopted a storiform arrangement, intermixed with thick collagen bundles ( Figure   3A and B). In the immunohistochemical study, the cytokeratins and the HMB45 were negative, whereas the CD68 was marked strongly positive ( Figure 3C , D and E).
Discussion
Malignant fibrohistiocytic tumors include various soft tissue sarcomas that show a spectrum of peculiar clinical-pathoor other procedure was reported. There were no regional lymphadenopathies.
Dermoscopy showed a shiny white-red structureless area with crystalline structures such as short white streaks and rosettes, the latter term used to designate four closely aggregated white, small dots in correspondence to a follicular opening arranged in a rhombus [5] . Observation | Dermatol Pract Concept 2017;7(3):9
The dermoscopic findings were not conclusive: the presence of erythema and a shiny white-red structureless area along with short white streaks and rosettes primarily suggested a squamous tumor and less likely a basal cell carcinoma. The findings were not specific for melanocytic lesion or non-melanocytic lesion, so according to the two-step algorithm, the diagnosis of melanoma cannot be ruled out and biopsy is mandatory.
Tumor size and depth have been identified as the main prognostic factors [8] . Therefore, establishing an accurate and early diagnosis is of crucial in improving the tumor prognosis.
To Approximately two-thirds of the tumors are located within the skeletal muscle, with fewer than 10% confined to the subcutis [7] . It usually presents as a slow-growing tumorous lesion, though there is no clinically characteristic presentation that allows for differentiation from other sarcomas.
The definitive diagnosis of MFH relies on histological studies, while immunohistochemistry helps establish the differential diagnosis with other entities with similar morphological patterns, such as pleomorphic varieties of rhabdomyosarcoma, leiomyosarcoma, liposarcoma, dermatofibrosarcoma protuberans, melanoma and atypical fibroxanthoma.
